Gliadel
Showing 1 - 25 of 48
Brain Tumor - Metastatic Trial in Omaha (Carmustine 7.7Mg Wafer)
Recruiting
- Brain Tumor - Metastatic
- Carmustine 7.7Mg Wafer
-
Omaha, NebraskaUniversity of Nebraska Medical Center
Sep 27, 2021
Glioblastoma, Gliosarcoma Trial in Seattle (radiation, procedure, drug, biological, other)
Completed
- Glioblastoma
- Gliosarcoma
- 3-Dimensional Conformal Radiation Therapy
- +10 more
-
Seattle, WashingtonFred Hutch/University of Washington Cancer Consortium
Mar 4, 2022
HIV Infection, Mature T-Cell and NK-Cell Non-Hodgkin Lymphoma, Plasmablastic Lymphoma Trial in United States (procedure, drug,
Recruiting
- HIV Infection
- +10 more
- Autologous Hematopoietic Stem Cell Transplantation
- +7 more
-
La Jolla, California
- +3 more
Dec 7, 2022
Autoimmune Disease, Neurologic Autoimmune Disease, Autologous Transplant Autoimmune Trial in Denver, Seattle (biological,
Recruiting
- Autoimmune Disease
- +18 more
- Anti-Thymocyte Globulin
- +9 more
-
Denver, Colorado
- +2 more
Feb 1, 2023
Hematopoietic Cell Transplantation Recipient, Recurrent DLBCL, Recurrent Grade 1 Follicular Lymphoma Trial in Columbus
Active, not recruiting
- Hematopoietic Cell Transplantation Recipient
- +11 more
- Carmustine
- +5 more
-
Columbus, OhioOhio State University Comprehensive Cancer Center
Sep 29, 2021
Glioma, Glioblastoma Multiforme, Astrocytoma Trial (Conventional RT, Hyperfractionated RT, Carmustine)
Completed
- Glioma
- +2 more
- Conventional RT
- +2 more
- (no location specified)
Nov 7, 2019
Magnetic Resonance Imaging and Magnetic Resonance Spectroscopy
Withdrawn
- Glioblastoma Multiforme
- +2 more
- MRS Spectroscopy
-
New York, New YorkWeill Cornell Medical College Department of Neurosurgery
May 30, 2019
Glioblastoma Multiforme Trial in Cincinnati (BCNU Wafer, Irinotecan, Bevacizumab)
Withdrawn
- Glioblastoma Multiforme
- BCNU Wafer
- +2 more
-
Cincinnati, OhioUniversity of Cincinnati
Nov 21, 2019
Brain and CNS Tumors Trial in Newport Beach (lymphokine-activated killer cells, polifeprosan 20 with carmustine implant)
Withdrawn
- Brain and Central Nervous System Tumors
- lymphokine-activated killer cells
- polifeprosan 20 with carmustine implant
-
Newport Beach, CaliforniaHoag Cancer Institute at Hoag Memorial Hospital Presbyterian
May 9, 2019
Glioblastoma Multiforme, Gliosarcoma Trial in Durham (Gliadel, Radiation Therapy, Avastin)
Terminated
- Glioblastoma Multiforme
- Gliosarcoma
- Gliadel
- +3 more
-
Durham, North CarolinaThe Preston Robert Tisch Brain Tumor Center
Jan 30, 2019
Burkitt Lymphoma, CD20-Positive Neoplastic Cells Present, DLBCL Trial in Seattle (biological, procedure, drug, radiation, other)
Terminated
- Burkitt Lymphoma
- +6 more
- Anti-CD20 B9E9 scFv-Streptavidin Fusion Protein
- +11 more
-
Seattle, WashingtonFred Hutch/University of Washington Cancer Consortium
Oct 30, 2020
Recurrent B-Cell Non-Hodgkin Lymphoma, Recurrent Hodgkin Lymphoma, Recurrent Mantle Cell Lymphoma Trial in Seattle (procedure,
Completed
- Recurrent B-Cell Non-Hodgkin Lymphoma
- +7 more
- Autologous Hematopoietic Stem Cell Transplantation
- +7 more
-
Seattle, WashingtonFred Hutch/University of Washington Cancer Consortium
Jul 29, 2020
Gliadel Wafer-Investigation of Vital Prognosis in High Grade
Completed
- Malignant Glioma
- No intervention
-
Osaka, Japan
- +1 more
Nov 2, 2018
Adult DLBCL, B-Cell Non-Hodgkin Lymphoma, Follicular Lymphoma Trial in Seattle (Autologous Hematopoietic Stem Cell
Completed
- Adult Diffuse Large B-Cell Lymphoma
- +5 more
- Autologous Hematopoietic Stem Cell Transplantation
- +7 more
-
Seattle, WashingtonFred Hutchinson Cancer Research Center/University of Washington
Mar 3, 2020
Brain and CNS Tumors Trial in Baltimore (temozolomide, adjuvant therapy, chemo)
Terminated
- Brain and Central Nervous System Tumors
- temozolomide
- +3 more
-
Baltimore, MarylandSidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Jun 25, 2018
CD19 Positive, Mantle Cell Lymphoma, Recurrent DLBCL Trial in Houston (procedure, drug, biological)
Withdrawn
- CD19 Positive
- +6 more
- Autologous Hematopoietic Stem Cell Transplantation
- +7 more
-
Houston, TexasM D Anderson Cancer Center
Jan 27, 2020
MicroRNA-10b in Patients With Gliomas
Recruiting
- Astrocytoma
- +8 more
-
Boston, Massachusetts
- +3 more
May 30, 2021
Prolymphocytic Leukemia, Recurrent Adult Hodgkin Lymphoma, Recurrent Childhood Hodgkin Lymphoma Trial in Salt Lake City,
Completed
- Prolymphocytic Leukemia
- +13 more
- Autologous Hematopoietic Stem Cell Transplantation
- +14 more
-
Salt Lake City, Utah
- +4 more
Jan 17, 2020
Anaplastic Large Cell Lymphoma, ALK-Negative, Recurrent Anaplastic Large Cell Lymphoma, Recurrent Mantle Cell Lymphoma Trial in
Completed
- Anaplastic Large Cell Lymphoma, ALK-Negative
- +5 more
- Autologous Hematopoietic Stem Cell Transplantation
- +6 more
-
Westwood, Kansas
- +2 more
Nov 7, 2019
B-Cell Prolymphocytic Leukemia, Hypodiploidy, Loss of Chromosome 17p Trial in Seattle, Milwaukee (procedure, drug, other,
Completed
- B-Cell Prolymphocytic Leukemia
- +20 more
- Allogeneic Bone Marrow Transplantation
- +14 more
-
Seattle, Washington
- +1 more
May 31, 2019
Glioblastoma Trial in United Kingdom (5-ALA, Gliadel wafers, Radiotherapy as normal based on standard clinical protocols
Recurrent Primary Cutaneous T-Cell Non-Hodgkin Lymphoma, Stage I Mycosis Fungoides and Sezary Syndrome AJCC v7, Stage II Mycosis
Completed
- Recurrent Primary Cutaneous T-Cell Non-Hodgkin Lymphoma
- +2 more
- Carmustine
- +2 more
-
Detroit, Michigan
- +3 more
Apr 23, 2018
Glioblastoma Trial in Tel Aviv (NovoTTF-200A)
Unknown status
- Glioblastoma
- NovoTTF-200A
-
Tel Aviv, IsraelTel Aviv saurasky medical center
Mar 8, 2019
Gliadel 7.7mg Implant (All-case Observational Study)
Completed
- Malignant Glioma
- No intervention
-
Osaka, Japan
- +1 more
Feb 23, 2017